Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer.
Curti BD, Ochoa AC, Powers GC, Kopp WC, Alvord WG, Janik JE, Gause BL, Dunn B, Kopreski MS, Fenton R, Zea A, Dansky-Ullmann C, Strobl S, Harvey L, Nelson E, Sznol M, Longo DL.
Curti BD, et al. Among authors: janik je.
J Clin Oncol. 1998 Aug;16(8):2752-60. doi: 10.1200/JCO.1998.16.8.2752.
J Clin Oncol. 1998.
PMID: 9704728
Clinical Trial.